7DOC image
Deposition Date 2020-12-14
Release Date 2021-04-14
Last Version Date 2024-07-10
Entry Detail
PDB ID:
7DOC
Keywords:
Title:
Crystal structure of Zika NS2B-NS3 protease with compound 5
Biological Source:
Source Organism:
Zika virus (Taxon ID: 64320)
synthetic construct (Taxon ID: 32630)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.22
R-Value Work:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Core protein
Chain IDs:A, G
Chain Length:39
Number of Molecules:2
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:Core protein
Chain IDs:B
Chain Length:153
Number of Molecules:1
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:Genome polyprotein
Chain IDs:C
Chain Length:38
Number of Molecules:1
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:Core protein
Chain IDs:D
Chain Length:152
Number of Molecules:1
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:Serine protease subunit NS2B
Chain IDs:E
Chain Length:39
Number of Molecules:1
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:Core protein
Chain IDs:F
Chain Length:158
Number of Molecules:1
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:Genome polyprotein
Chain IDs:H
Chain Length:153
Number of Molecules:1
Biological Source:Zika virus
Polymer Type:polypeptide(L)
Molecule:3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE
Chain IDs:I
Chain Length:5
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
2-Cyanoisonicotinamide Conjugation: A Facile Approach to Generate Potent Peptide Inhibitors of the Zika Virus Protease.
Acs Med.Chem.Lett. 12 732 737 (2021)
PMID: 34055219 DOI: 10.1021/acsmedchemlett.0c00657

Abstact

The rapid generation and modification of macrocyclic peptides in medicinal chemistry is an ever-growing area that can present various synthetic challenges. The reaction between N-terminal cysteine and 2-cyanoisonicotinamide is a new biocompatible click reaction that allows rapid access to macrocyclic peptides. Importantly, 2-cyanoisonicotinamide can be attached to different linkers directly during solid-phase peptide synthesis. The synthesis involves only commercially available precursors, allowing for a fully automated process. We demonstrate the approach for four cyclic peptide ligands of the Zika virus protease NS2B-NS3. Although all peptides display the substrate recognition motif, the activity strongly depends on the linker length, with the shortest cyclization linker corresponding to highest activity (K i = 0.64 μM). The most active cyclic peptide displays affinity 78 times higher than that of its linear analogue. We solved a crystal structure of the proteolytically cleaved ligand and synthesized it by applying the presented chemistry to peptide ligation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures